en · de · es · fr · pt
sr9009-notes.peptides6088.com › Wiki › Identity, Handling, And Regulation — Quick Reference

Identity, Handling, And Regulation — Quick Reference

By Editorial Desk · published 2025-10-28 · last reviewed 2025-12-17 · Wiki

Everything below concerns analytical standard. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2025-12-17. Where a claim depends on a specific study, the study is described rather than over-claimed.

Identity, Handling, and Regulation

In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.

Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.

Mechanism and Preclinical Findings

Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.

The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.

Sr9009 at a glance

PropertyValueNotes
AppearanceWhite to off-white solidVisual inspection is not sufficient for identity.
SolubilitySoluble in DMSO and ethanolLow solubility in water.
Typical storage-20 °C, desiccated, darkProtect from repeated temperature changes.
Common analytical methodLC-MS or HPLC-UVReference standard required for comparison.
Common synonymsSR9009; Stenabolic; REV-ERB agonistVendor naming may vary.

Handling Storage and Quality Control

Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.

Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.

Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.

Related pages on this site

SR9009 Identity and Mechanism

REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.

SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.

Reference notes

== Exact solutions of the Navier–Stokes equations == Some exact solutions to the Navier–Stokes equations exist. Examples of degenerate cases—with the non-linear terms in the Navier–Stokes equations equal to zero—are Poiseuille flow, Couette flow and the oscillatory Stokes boundary layer. But also, more interesting examples, solutions to the full non-linear equations, exist, such as Jeffery–Hamel flow, Von Kármán swirling flow, stagnation point flow, Landau–Squire jet, and Taylor–Green vortex. Time-dependent self-similar solutions of the three-dimensional non-compressible Navier–Stokes equations in Cartesian coordinate can be given with the help of the Kummer's functions with quadratic arguments. For the compressible Navier–Stokes equations the time-dependent self-similar solutions are however the Whittaker functions again with quadratic arguments when the polytropic equation of state is used as a closing condition. Note that the existence of these exact solutions does not imply they are stable: turbulence may develop at higher Reynolds numbers. Under additional assumptions, the component parts can be separated.

===== Accelerated hair re-growth ===== Hair returns to the brand site with the next hair cycle in darker animals, but the loss after a month is permanent for pale-coated animals. Around two months after branding white hair will begin to grow on darker animals. This white hair often grows much more quickly than the rest of the coat and may eventually grow long enough to overlap the surrounding, pigmented hair. This boost occurs because growth follicles no longer compete for energy with the dormant or dead melanocytes. Under normal conditions, this competition is one of the key checks on the speed of hair growth.

== History == Historical descriptions of possible PMOS symptoms date to ancient Greece, where Hippocrates described women with "thick, oily skin and absence of menstruation." The earliest known description of what is now recognized as PMOS dates from 1721 in Italy, which described "Young married peasant women, moderately obese and infertile, with two larger than normal ovaries, bumpy, shiny and whitish, just like pigeon eggs". Polycystic ovaries were likely first formally described in 1844 by the French doctor Achille Chereau. In 1935, American gynecologists Irving F. Stein and Michael L. Leventhal published a report linking polycystic ovaries to hirsutism, infertility, and lack of periods. The report also hypothesised that PMOS results from endocrine dysfunction, initiating research into its hormonal causes and giving rise to the term Stein–Leventhal syndrome. By the 1980s, the metabolic side of PMOS started to be studied, before the start of genetics research in the 1990s.

Prolactin receptors are present in the mammillary glands, ovaries, pituitary glands, heart, lung, thymus, spleen, liver, pancreas, kidney, adrenal gland, uterus, skeletal muscle, skin and areas of the central nervous system. When prolactin binds to the receptor, it causes it to dimerize with another prolactin receptor. This results in the activation of Janus kinase 2, a tyrosine kinase that initiates the JAK-STAT pathway. Activation also results in the activation of mitogen-activated protein kinases and Src kinase. Human prolactin receptors are insensitive to mouse prolactin.

Sources: en.wikipedia.org

Notes from published material

Ion-attachment mass spectrometry (IAMS) is a form of mass spectrometry that uses a "soft" form of ionization similar to chemical ionization in which a cation is attached to the analyte molecule in a reactive collision,

== See also == RO5073012 – TAAR1 weak partial agonist RO5166017 – TAAR1 partial or full agonist RO5203648 – TAAR1 partial agonist RO5256390 – TAAR1 partial or full agonist EPPTB – TAAR1 antagonist/inverse agonist

Because of its extreme reactivity with oxygen and water, strontium occurs naturally only in compounds with other elements, such as in the minerals strontianite and celestine. It is kept under a liquid hydrocarbon such as mineral oil or kerosene to prevent oxidation; freshly exposed strontium metal rapidly turns a yellowish color with the formation of the oxide. Finely powdered strontium metal is pyrophoric, meaning that it will ignite spontaneously in air at room temperature. Volatile strontium salts impart a bright red color to flames, and these salts are used in pyrotechnics and in the production of flares. Like calcium and barium, as well as the alkali metals and the divalent lanthanides europium and ytterbium, strontium metal dissolves directly in liquid ammonia to give a dark blue solution of solvated electrons.

=== Parasitic infections === Parasites are a diverse group of pathogens with significant health implications. Parasitic diseases can be transmitted through blood (e.g. malaria), contaminated water or food (e.g. Trichinella spiralis, Giardia duodenalis), penetration of skin or mucous membranes (e.g. Strongyloidiasis), and direct contact between hosts (e.g. Trichomonas vaginalis). Mast cells (MCs) tend to be located in strategic positions such as the subepithelial layers of skin, the respiratory system, the gastrointestinal tract, the genitourinary tract, and around blood vessels or nerves. Interactions between parasite and host are complex, involving parasite evasion strategies, host defense mechanisms, and continuous adaptation of both. Due to their strategic location in the host-environment interface MCs can provide rapid response capability. MCs can be activated in a parasite-specific manner through the detection of highly specialized molecular patterns related to pathogens (PAMPs) and microbes (MAMPs). The most characteristic feature of the immune system's response to parasite attack is the binding of immunoglobulin E (IgE) to the FcεRI receptor, which triggers MC degranulation and the release of mediators. These, in turn, trigger IgE-mediated type 2 responses, characterized by signaling from IL-4, IL-5, and IL-13. In responding to infection, mast cells orchestrate both first-line innate immune responses and adaptive immune processes in a variety of cell types.

adenosyl radical, which converts to deoxyadenosine (AdO): classic rSAM reaction, also cogenerates methionine S-adenosyl homocysteine, releasing methyl radical methylthioadenosine (SMT), homoalanine radical

Sources: en.wikipedia.org

Background from the literature

osmotic concentration maintained by the use of metabolically inert substances like lactobionate and raffinose rather than with glucose Hydroxyethyl starch (HES) is used to prevent edema Substances are added to scavenge free radicals, along with steroids and insulin.

==== Suicides ==== On January 17, 2020, a video titled "Medical Help" was uploaded to YouTube by 26-year-old Wail Ardab of Palatka, Florida, who developed dystonia and insomnia after taking Invega Trinza injections. On March 5, 2020, Ardab committed suicide by jumping from Memorial Bridge in Palatka. From June 2023 to April 2024, Serbian television presenter and journalist Bojana Nikolić Janković posted to the internet forum Bluelight that she received 4 shots of Invega Sustenna and 2 shots of Invega Trinza due to the stress of her divorce from Ognjen Janković, a member of the hip-hop group Beogradski Sindikat. Janković, known for hosting the show City, wrote that she was bedridden with persistent anhedonia, cognitive issues, low energy and other symptoms consistent with neuroleptic-induced deficit syndrome after receiving the injections. She died in Belgrade on April 19, 2024, at age 46.

==== Ergolines (non-selective monoamine receptor modulators) ==== Dihydroergotamine (DHE; INP-104; POD-DHE; Trudhesa) – non-selective monoamine receptor modulator and ergoline – migraine [128] Dihydroergotamine mesilate intranasal (Atzumi; STS-101; TO-2070) – non-selective monoamine receptor modulator and ergoline – migraine [129] Dihydroergotamine mesylate intranasal (Migranal) – non-selective monoamine receptor modulator and ergoline – migraine [130]

From the late 18th century it became apparent that a crystal of a substance was composed of units, whether thought of as atoms, ions, molecules, or polyhedra, in a regular spatial arrangement, termed its crystal structure. The most notable early theory for crystal structures was that of René Just Haüy. In 1801 Haüy, published his Traité de Minéralogie in four volumes, the last of which was an atlas of plates which was considered "among the most wonderful of the 19th century". It has been described as "a work of comprehensive insight, and much of it, written with literary fluency". In this work Haüy described how the law of rational indices establishes relationships between the orientations of the crystal faces, and explains that crystalline solids are formed by replicas of what would now be considered a unit cell. Haüy's theory called for fixed mineral species (based on their molécule intégrante), fixed crystal morphology, and constant chemical composition. This was a mineralogical equivalent to the law of definite proportions in chemistry. John G. Burke (1966) and Hans-Werner Schütt (1984) proposed Haüy's crystal structure theory as an example of a paradigm in the sense of The Structure of Scientific Revolutions by Thomas S. Kuhn (1962). In 1822 Haüy published Traité de Cristallographie an updated version of his work of 1801.

Sources: en.wikipedia.org

Frequently asked questions

How is SR9009 usually analyzed?

Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.

What storage conditions are typical?

The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.

Is SR9009 legal to purchase?

Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.

What is SR9009?

It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.

Network